FOLD logo

Amicus Therapeutics (FOLD) Retained earnings

annual retained earnings:

-$2.74B-$56.11M(-2.09%)
December 31, 2024

Summary

  • As of today (May 25, 2025), FOLD annual retained earnings is -$2.74 billion, with the most recent change of -$56.11 million (-2.09%) on December 31, 2024.
  • During the last 3 years, FOLD annual retained earnings has fallen by -$444.26 million (-19.35%).
  • FOLD annual retained earnings is now -32126.04% below its all-time high of -$8.50 million, reached on December 31, 2003.

Performance

FOLD Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

quarterly retained earnings:

-$2.76B-$21.69M(-0.79%)
March 31, 2025

Summary

  • As of today (May 25, 2025), FOLD quarterly retained earnings is -$2.76 billion, with the most recent change of -$21.69 million (-0.79%) on March 31, 2025.
  • Over the past year, FOLD quarterly retained earnings has dropped by -$29.37 million (-1.07%).
  • FOLD quarterly retained earnings is now -7300.02% below its all-time high of -$37.32 million, reached on December 31, 2005.

Performance

FOLD quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

FOLD Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.1%-1.1%
3 y3 years-19.4%-16.0%
5 y5 years-54.9%-48.7%

FOLD Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-19.4%at low-16.0%at low
5 y5-year-54.9%at low-48.7%at low
alltimeall time<-9999.0%at low-7300.0%at low

FOLD Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$2.76B(+0.8%)
Dec 2024
-$2.74B(+2.1%)
-$2.74B(-0.5%)
Sep 2024
-
-$2.75B(+0.2%)
Jun 2024
-
-$2.75B(+0.6%)
Mar 2024
-
-$2.73B(+1.8%)
Dec 2023
-$2.68B(+6.0%)
-$2.68B(+1.3%)
Sep 2023
-
-$2.65B(+0.8%)
Jun 2023
-
-$2.63B(+1.7%)
Mar 2023
-
-$2.59B(+2.1%)
Dec 2022
-$2.53B(+10.3%)
-$2.53B(+2.3%)
Sep 2022
-
-$2.48B(+1.4%)
Jun 2022
-
-$2.44B(+2.6%)
Mar 2022
-
-$2.38B(+3.7%)
Dec 2021
-$2.30B(+12.2%)
-$2.30B(+3.8%)
Sep 2021
-
-$2.21B(+2.3%)
Jun 2021
-
-$2.16B(+2.4%)
Mar 2021
-
-$2.11B(+3.2%)
Dec 2020
-$2.05B(+15.7%)
-$2.05B(+3.6%)
Sep 2020
-
-$1.97B(+3.4%)
Jun 2020
-
-$1.91B(+2.8%)
Mar 2020
-
-$1.86B(+5.0%)
Dec 2019
-$1.77B(+25.2%)
-$1.77B(+5.3%)
Sep 2019
-
-$1.68B(+3.8%)
Jun 2019
-
-$1.62B(+5.5%)
Mar 2019
-
-$1.53B(+8.5%)
Dec 2018
-$1.41B(+32.8%)
-$1.41B(+5.9%)
Sep 2018
-
-$1.33B(+13.5%)
Jun 2018
-
-$1.17B(+5.6%)
Mar 2018
-
-$1.11B(+4.7%)
Dec 2017
-$1.06B(+36.4%)
-$1.06B(+7.0%)
Sep 2017
-
-$994.40M(+12.6%)
Jun 2017
-
-$882.74M(+5.8%)
Mar 2017
-
-$834.60M(+7.1%)
Dec 2016
-$779.61M(+34.5%)
-$779.61M(+8.1%)
Sep 2016
-
-$720.96M(+6.9%)
Jun 2016
-
-$674.31M(+8.2%)
Mar 2016
-
-$623.26M(+7.5%)
Dec 2015
-$579.57M
-$579.57M(+8.0%)
DateAnnualQuarterly
Sep 2015
-
-$536.67M(+7.6%)
Jun 2015
-
-$498.87M(+5.8%)
Mar 2015
-
-$471.74M(+5.4%)
Dec 2014
-$447.45M(+18.2%)
-$447.45M(+5.0%)
Sep 2014
-
-$426.23M(+4.2%)
Jun 2014
-
-$409.08M(+3.7%)
Mar 2014
-
-$394.46M(+4.2%)
Dec 2013
-$378.52M(+18.7%)
-$378.52M(+3.3%)
Sep 2013
-
-$366.29M(+4.1%)
Jun 2013
-
-$351.70M(+4.6%)
Mar 2013
-
-$336.35M(+5.5%)
Dec 2012
-$318.89M(+18.1%)
-$318.89M(+3.2%)
Sep 2012
-
-$308.87M(+5.6%)
Jun 2012
-
-$292.58M(+3.3%)
Mar 2012
-
-$283.24M(+4.9%)
Dec 2011
-$270.10M(+19.7%)
-$270.10M(+3.3%)
Sep 2011
-
-$261.44M(+3.9%)
Jun 2011
-
-$251.68M(+5.3%)
Mar 2011
-
-$239.04M(+5.9%)
Dec 2010
-$225.69M(+32.2%)
-$225.69M(+7.2%)
Sep 2010
-
-$210.60M(+7.9%)
Jun 2010
-
-$195.25M(+6.2%)
Mar 2010
-
-$183.93M(+7.7%)
Dec 2009
-$170.76M(+4.0%)
-$170.76M(-16.2%)
Sep 2009
-
-$203.71M(+7.1%)
Jun 2009
-
-$190.28M(+7.7%)
Mar 2009
-
-$176.66M(+7.6%)
Dec 2008
-$164.19M(+31.5%)
-$164.19M(+9.4%)
Sep 2008
-
-$150.04M(+5.8%)
Jun 2008
-
-$141.86M(+7.0%)
Mar 2008
-
-$132.56M(+6.2%)
Dec 2007
-$124.83M(+49.2%)
-$124.83M(+10.4%)
Sep 2007
-
-$113.06M(+10.0%)
Jun 2007
-
-$102.76M(+10.1%)
Mar 2007
-
-$93.36M(+11.6%)
Dec 2006
-$83.67M(+124.2%)
-$83.67M(+124.2%)
Dec 2005
-$37.32M(+338.9%)
-$37.32M
Dec 2003
-$8.50M
-

FAQ

  • What is Amicus Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Amicus Therapeutics?
  • What is Amicus Therapeutics annual retained earnings year-on-year change?
  • What is Amicus Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly retained earnings year-on-year change?

What is Amicus Therapeutics annual retained earnings?

The current annual retained earnings of FOLD is -$2.74B

What is the all time high annual retained earnings for Amicus Therapeutics?

Amicus Therapeutics all-time high annual retained earnings is -$8.50M

What is Amicus Therapeutics annual retained earnings year-on-year change?

Over the past year, FOLD annual retained earnings has changed by -$56.11M (-2.09%)

What is Amicus Therapeutics quarterly retained earnings?

The current quarterly retained earnings of FOLD is -$2.76B

What is the all time high quarterly retained earnings for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly retained earnings is -$37.32M

What is Amicus Therapeutics quarterly retained earnings year-on-year change?

Over the past year, FOLD quarterly retained earnings has changed by -$29.37M (-1.07%)
On this page